RU2015113595A - Комбинация хромофоров для биофотонных применений - Google Patents
Комбинация хромофоров для биофотонных применений Download PDFInfo
- Publication number
- RU2015113595A RU2015113595A RU2015113595A RU2015113595A RU2015113595A RU 2015113595 A RU2015113595 A RU 2015113595A RU 2015113595 A RU2015113595 A RU 2015113595A RU 2015113595 A RU2015113595 A RU 2015113595A RU 2015113595 A RU2015113595 A RU 2015113595A
- Authority
- RU
- Russia
- Prior art keywords
- composition
- therapy
- xanthene dye
- xanthene
- biophoton
- Prior art date
Links
- 239000001018 xanthene dye Substances 0.000 claims abstract 47
- 238000002560 therapeutic procedure Methods 0.000 claims abstract 42
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 claims abstract 12
- SEACYXSIPDVVMV-UHFFFAOYSA-L eosin Y Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 SEACYXSIPDVVMV-UHFFFAOYSA-L 0.000 claims abstract 12
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims abstract 12
- 230000000699 topical effect Effects 0.000 claims abstract 11
- 238000000862 absorption spectrum Methods 0.000 claims abstract 10
- 238000000295 emission spectrum Methods 0.000 claims abstract 4
- 230000004913 activation Effects 0.000 claims abstract 2
- 238000001429 visible spectrum Methods 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims 11
- 210000001519 tissue Anatomy 0.000 claims 11
- 210000003491 skin Anatomy 0.000 claims 6
- 208000017520 skin disease Diseases 0.000 claims 4
- 208000027418 Wounds and injury Diseases 0.000 claims 3
- 230000003213 activating effect Effects 0.000 claims 3
- 230000001678 irradiating effect Effects 0.000 claims 3
- 230000003716 rejuvenation Effects 0.000 claims 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 2
- 230000031700 light absorption Effects 0.000 claims 2
- 230000001737 promoting effect Effects 0.000 claims 2
- 102100034871 C-C motif chemokine 8 Human genes 0.000 claims 1
- 101710155833 C-C motif chemokine 8 Proteins 0.000 claims 1
- 102100036150 C-X-C motif chemokine 5 Human genes 0.000 claims 1
- 102000008186 Collagen Human genes 0.000 claims 1
- 108010035532 Collagen Proteins 0.000 claims 1
- 101100441523 Homo sapiens CXCL5 gene Proteins 0.000 claims 1
- 101000852968 Homo sapiens Interleukin-1 receptor-like 1 Proteins 0.000 claims 1
- 101001013150 Homo sapiens Interstitial collagenase Proteins 0.000 claims 1
- 101000990908 Homo sapiens Neutrophil collagenase Proteins 0.000 claims 1
- 101000990915 Homo sapiens Stromelysin-1 Proteins 0.000 claims 1
- 101000577874 Homo sapiens Stromelysin-2 Proteins 0.000 claims 1
- 101000585365 Homo sapiens Sulfotransferase 2A1 Proteins 0.000 claims 1
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 claims 1
- 102100030411 Neutrophil collagenase Human genes 0.000 claims 1
- 206010072170 Skin wound Diseases 0.000 claims 1
- 102100030416 Stromelysin-1 Human genes 0.000 claims 1
- 102100028848 Stromelysin-2 Human genes 0.000 claims 1
- 102100029867 Sulfotransferase 2A1 Human genes 0.000 claims 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims 1
- 230000033115 angiogenesis Effects 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 229920001436 collagen Polymers 0.000 claims 1
- 210000004207 dermis Anatomy 0.000 claims 1
- 210000002615 epidermis Anatomy 0.000 claims 1
- 230000035876 healing Effects 0.000 claims 1
- 230000020169 heat generation Effects 0.000 claims 1
- AEUKDPKXTPNBNY-XEYRWQBLSA-N mcp 2 Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C1=CC=CC=C1 AEUKDPKXTPNBNY-XEYRWQBLSA-N 0.000 claims 1
- 239000007800 oxidant agent Substances 0.000 claims 1
- 230000000717 retained effect Effects 0.000 claims 1
- 238000001228 spectrum Methods 0.000 claims 1
- 230000017423 tissue regeneration Effects 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/22—Peroxides; Oxygen; Ozone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0616—Skin treatment other than tanning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/062—Photodynamic therapy, i.e. excitation of an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B67/00—Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
- C09B67/0033—Blends of pigments; Mixtured crystals; Solid solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/26—Optical properties
- A61K2800/262—Transparent; Translucent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/42—Colour properties
- A61K2800/43—Pigments; Dyes
- A61K2800/434—Luminescent, Fluorescent; Optical brighteners; Photosensitizers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/81—Preparation or application process involves irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A61N2005/0645—Applicators worn by the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A61N2005/0645—Applicators worn by the patient
- A61N2005/0647—Applicators worn by the patient the applicator adapted to be worn on the head
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
- A61N2005/0663—Coloured light
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Radiology & Medical Imaging (AREA)
- Pathology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Radiation-Therapy Devices (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (17)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261701513P | 2012-09-14 | 2012-09-14 | |
| US201261701502P | 2012-09-14 | 2012-09-14 | |
| US201261701510P | 2012-09-14 | 2012-09-14 | |
| US61/701,502 | 2012-09-14 | ||
| US61/701,513 | 2012-09-14 | ||
| US61/701,510 | 2012-09-14 | ||
| US201361766611P | 2013-02-19 | 2013-02-19 | |
| US61/766,611 | 2013-02-19 | ||
| US13/830,488 | 2013-03-14 | ||
| US13/830,488 US20130281913A1 (en) | 2012-04-20 | 2013-03-14 | Biophotonic compositions and methods for providing biophotonic treatment |
| GB1307157.6 | 2013-04-19 | ||
| CAPCT/CA2013/000395 | 2013-04-19 | ||
| GB1307157.6A GB2499921B (en) | 2012-04-20 | 2013-04-19 | Biophotonic compositions, kits and methods |
| PCT/CA2013/000395 WO2013155620A1 (en) | 2012-04-20 | 2013-04-19 | Biophotonic compositions, kits and methods |
| US201361873791P | 2013-09-04 | 2013-09-04 | |
| US61/873,791 | 2013-09-04 | ||
| PCT/CA2013/000786 WO2014040176A1 (en) | 2012-09-14 | 2013-09-13 | Chromophore combinations for biophotonic uses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2015113595A true RU2015113595A (ru) | 2016-11-10 |
Family
ID=50277449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2015113595A RU2015113595A (ru) | 2012-09-14 | 2013-09-13 | Комбинация хромофоров для биофотонных применений |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20190133908A1 (enExample) |
| EP (3) | EP2895194A4 (enExample) |
| JP (3) | JP2015528472A (enExample) |
| KR (3) | KR20150068358A (enExample) |
| CN (1) | CN104755101B (enExample) |
| AU (1) | AU2013315303B2 (enExample) |
| BR (1) | BR112015005382A2 (enExample) |
| HK (2) | HK1212592A1 (enExample) |
| IL (1) | IL237657A0 (enExample) |
| IN (1) | IN2015DN02938A (enExample) |
| MX (1) | MX367670B (enExample) |
| RU (1) | RU2015113595A (enExample) |
| WO (1) | WO2014040176A1 (enExample) |
| ZA (1) | ZA201501700B (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT2352488T (lt) | 2008-11-07 | 2017-05-25 | Klox Technologies Inc. | Oksidacinė fotoaktyvuojama odos atjauninimo kompozicija, apimanti hialurono rūgštį, gliukozaminą arba alantoiną |
| SMT201700575T1 (it) | 2009-07-17 | 2018-01-11 | Klox Tech Inc | Composizione orale antibatterica |
| US20130281913A1 (en) | 2012-04-20 | 2013-10-24 | Klox Technologies Inc. | Biophotonic compositions and methods for providing biophotonic treatment |
| US11116841B2 (en) | 2012-04-20 | 2021-09-14 | Klox Technologies Inc. | Biophotonic compositions, kits and methods |
| WO2014040176A1 (en) * | 2012-09-14 | 2014-03-20 | Klox Technologies Inc. | Chromophore combinations for biophotonic uses |
| KR20150068357A (ko) * | 2012-09-14 | 2015-06-19 | 클록스 테크놀로지스 인크. | 화장용 생체 광자성 조성물 |
| US20140276354A1 (en) | 2013-03-14 | 2014-09-18 | Klox Technologies Inc. | Biophotonic materials and uses thereof |
| WO2015000058A1 (en) | 2013-07-03 | 2015-01-08 | Klox Technologies Inc. | Biophotonic compositions comprising a chromophore and a gelling agent for treating wounds |
| AU2015240385B2 (en) | 2014-04-01 | 2019-02-28 | Klox Technologies Inc. | Tissue filler compositions and methods of use |
| AU2015271615A1 (en) * | 2014-06-04 | 2016-12-08 | Klox Technologies Inc. | Biophotonic hydrogels |
| CA2951513A1 (en) | 2014-06-09 | 2015-12-17 | Klox Technologies Inc. | Silicone-based biophotonic compositions and uses thereof |
| AU2015318541A1 (en) * | 2014-09-15 | 2017-03-16 | Klox Technologies Inc. | Emissive polymeric matrices |
| JP2018500468A (ja) * | 2014-10-31 | 2018-01-11 | クロックス テクノロジーズ インコーポレイテッドＫｌｏｘ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． | 光活性性の繊維および織物媒体 |
| JP2016172705A (ja) * | 2015-03-17 | 2016-09-29 | 国立大学法人 東京大学 | Ｍｉｎｔ３阻害剤 |
| CA3011156A1 (en) * | 2016-01-11 | 2017-07-20 | Klox Technologies Limited | Biophotonic compositions for the treatment of otitis externa |
| EP3402523A4 (en) * | 2016-01-11 | 2019-07-24 | Francesco Bellini | BIOPHOTONIC COMPOSITIONS FOR THE TREATMENT OF PYODERMA |
| AU2017207536A1 (en) * | 2016-01-11 | 2018-07-26 | Vetoquinol Sa | Biophotonic compositions for treating skin and soft tissue wounds having either or both non-resistant and resistant infections |
| CA3021661A1 (en) * | 2016-05-20 | 2017-11-23 | Howard Hughes Medical Institute | Photoactive fluorophores and methods of in vivo labeling |
| US11207408B2 (en) | 2016-09-23 | 2021-12-28 | Klox Technologies Inc. | Biophotonic compositions, methods, and kits for inhibiting and disrupting biofilms |
| EP3515496A4 (en) * | 2016-09-23 | 2020-05-20 | Klox Technologies Inc. | BIOPHOTONIC COMPOSITIONS AND METHODS FOR REDUCING SCARGING |
| CA3051498A1 (en) * | 2017-01-27 | 2018-08-02 | Klox Technologies Inc. | Methods for photobiomodulation of biological processes using fluorescence generated and emitted from a biophotonic composition or a biophotonic system |
| US20200405858A1 (en) * | 2017-11-17 | 2020-12-31 | Klox Technologies Limited | Modulation of biophotonic regimens |
| US20210170027A1 (en) * | 2017-11-17 | 2021-06-10 | Klox Technologies Limited | Biophotonic compositions, methods and kits for enhancing hair growth |
| US10322297B1 (en) | 2018-08-21 | 2019-06-18 | Lumia Group, LLC | Electrically passive low-level light therapy system and methods incorporating same |
| KR102730110B1 (ko) * | 2018-10-18 | 2024-11-15 | 주식회사 엘지에너지솔루션 | 비수전해액 및 이를 포함하는 리튬 이차전지 |
| DE102022118867A1 (de) * | 2022-07-27 | 2024-02-01 | Thomas Klose | Gerät und Zusammensetzung zur Behandlung einer Wunde, Kartusche für das Gerät, Verfahren zur Herstellung der Zusammensetzung |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4320140A (en) * | 1980-10-09 | 1982-03-16 | Sterling Drug Inc. | Synergistic insecticidal compositions |
| US4647578A (en) * | 1983-12-02 | 1987-03-03 | Sterling Drug Inc. | Phototoxic insecticidal compositions and method of use thereof |
| JP2001513826A (ja) * | 1997-02-03 | 2001-09-04 | チバ スペシャルティ ケミカルズ ホールディング インコーポレーテッド | 蛍光材料及びそれらの使用 |
| US8974363B2 (en) * | 1997-12-11 | 2015-03-10 | Provectus Pharmatech, Inc. | Topical medicaments and methods for photodynamic treatment of disease |
| US6676655B2 (en) * | 1998-11-30 | 2004-01-13 | Light Bioscience L.L.C. | Low intensity light therapy for the manipulation of fibroblast, and fibroblast-derived mammalian cells and collagen |
| ATE406157T1 (de) * | 1999-08-13 | 2008-09-15 | Provectus Pharmatech Inc | Verbesserte topische medikamente sowie verfahren zur photodynamischer behandlung von krankheiten |
| US20050008892A1 (en) * | 2002-02-01 | 2005-01-13 | Hiroshi Yamamoto | Fluorescent compositions comprising diketopyrrolopyrroles |
| US20050059731A1 (en) * | 2003-09-16 | 2005-03-17 | Ceramoptec Industries, Inc. | Erythrosin-based antimicrobial photodynamic therapy compound and its use |
| US7344701B2 (en) * | 2004-02-03 | 2008-03-18 | Biosearch Technologies, Inc. | Xanthene dyes |
| EP2338465A1 (en) * | 2005-11-09 | 2011-06-29 | Klox Technologies Inc. | Teeth whitening compositions and methods |
| US20100266989A1 (en) * | 2006-11-09 | 2010-10-21 | Klox Technologies Inc. | Teeth whitening compositions and methods |
| LT2352488T (lt) * | 2008-11-07 | 2017-05-25 | Klox Technologies Inc. | Oksidacinė fotoaktyvuojama odos atjauninimo kompozicija, apimanti hialurono rūgštį, gliukozaminą arba alantoiną |
| SMT201700575T1 (it) * | 2009-07-17 | 2018-01-11 | Klox Tech Inc | Composizione orale antibatterica |
| GB201200490D0 (en) * | 2012-01-12 | 2012-02-22 | Univ Bath | Wound dressing |
| WO2014040176A1 (en) * | 2012-09-14 | 2014-03-20 | Klox Technologies Inc. | Chromophore combinations for biophotonic uses |
| US11116841B2 (en) * | 2012-04-20 | 2021-09-14 | Klox Technologies Inc. | Biophotonic compositions, kits and methods |
| US20130281913A1 (en) * | 2012-04-20 | 2013-10-24 | Klox Technologies Inc. | Biophotonic compositions and methods for providing biophotonic treatment |
-
2013
- 2013-09-13 WO PCT/CA2013/000786 patent/WO2014040176A1/en not_active Ceased
- 2013-09-13 KR KR1020157006411A patent/KR20150068358A/ko not_active Withdrawn
- 2013-09-13 AU AU2013315303A patent/AU2013315303B2/en not_active Ceased
- 2013-09-13 MX MX2015003361A patent/MX367670B/es active IP Right Grant
- 2013-09-13 RU RU2015113595A patent/RU2015113595A/ru not_active Application Discontinuation
- 2013-09-13 HK HK16100462.1A patent/HK1212592A1/zh unknown
- 2013-09-13 JP JP2015531408A patent/JP2015528472A/ja active Pending
- 2013-09-13 BR BR112015005382A patent/BR112015005382A2/pt not_active Application Discontinuation
- 2013-09-13 CN CN201380047508.0A patent/CN104755101B/zh active Active
- 2013-09-13 IN IN2938DEN2015 patent/IN2015DN02938A/en unknown
- 2013-09-13 KR KR1020217017420A patent/KR20210072827A/ko not_active Ceased
- 2013-09-13 EP EP13836318.9A patent/EP2895194A4/en not_active Withdrawn
- 2013-09-13 HK HK15109532.9A patent/HK1208807A1/xx unknown
- 2013-09-13 EP EP17196260.8A patent/EP3329938B1/en active Active
- 2013-09-13 KR KR1020187028357A patent/KR20180110240A/ko not_active Ceased
- 2013-09-13 EP EP16184973.2A patent/EP3153177A1/en not_active Withdrawn
-
2015
- 2015-03-10 IL IL237657A patent/IL237657A0/en unknown
- 2015-03-12 ZA ZA2015/01700A patent/ZA201501700B/en unknown
-
2017
- 2017-12-13 JP JP2017238941A patent/JP2018076343A/ja active Pending
-
2018
- 2018-12-19 US US16/225,672 patent/US20190133908A1/en not_active Abandoned
-
2021
- 2021-10-06 JP JP2021164474A patent/JP2022003081A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN104755101A (zh) | 2015-07-01 |
| BR112015005382A2 (pt) | 2019-11-26 |
| EP3329938B1 (en) | 2021-06-23 |
| KR20180110240A (ko) | 2018-10-08 |
| EP3153177A1 (en) | 2017-04-12 |
| KR20150068358A (ko) | 2015-06-19 |
| WO2014040176A1 (en) | 2014-03-20 |
| MX2015003361A (es) | 2015-10-22 |
| CN104755101B (zh) | 2018-10-02 |
| AU2013315303A1 (en) | 2015-03-19 |
| MX367670B (es) | 2019-08-30 |
| IL237657A0 (en) | 2015-04-30 |
| HK1208807A1 (en) | 2016-03-18 |
| EP2895194A4 (en) | 2016-03-09 |
| HK1212592A1 (zh) | 2016-06-17 |
| KR20210072827A (ko) | 2021-06-17 |
| JP2022003081A (ja) | 2022-01-11 |
| EP2895194A1 (en) | 2015-07-22 |
| AU2013315303B2 (en) | 2018-07-26 |
| ZA201501700B (en) | 2016-01-27 |
| JP2018076343A (ja) | 2018-05-17 |
| IN2015DN02938A (enExample) | 2015-09-18 |
| JP2015528472A (ja) | 2015-09-28 |
| EP3329938A1 (en) | 2018-06-06 |
| US20190133908A1 (en) | 2019-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2015113595A (ru) | Комбинация хромофоров для биофотонных применений | |
| JP2015528472A5 (enExample) | ||
| RU2015113528A (ru) | Косметические композиции для биофотонной терапии | |
| KR20180027643A (ko) | 광선 요법용 양자점 발광 다이오드 | |
| Lima et al. | Photobiomodulation via multiple-wavelength radiations | |
| RU2010126148A (ru) | Композиция для фотодинамического лечения кожи | |
| CN203970547U (zh) | 一种出射均匀光斑的半导体激光器医疗模组 | |
| WO2006015493A1 (en) | Method for the treatment of mammalian skin tissues via pulse irradiation in the presence of a photoactive compound | |
| JP2017517537A5 (enExample) | ||
| Bordin-Aykroyd et al. | Laser-tissue interaction | |
| RU2016151724A (ru) | Термоотверждаемые биофотонные композиции и их применения | |
| CN202070020U (zh) | 一种led光动力治疗仪 | |
| CN203220691U (zh) | 一种激光光动力治疗仪 | |
| Jalili | Chromophore gel-assisted phototherapy: A novel and promising photobiomodulation therapy for facial inflammatory skin diseases and skin aging | |
| RU2010122692A (ru) | Способ лечения поверхностного рака мочевого пузыря | |
| CN104147705A (zh) | 一种可产生时变光强输出的光子治疗装置 | |
| US20070231307A1 (en) | Energy assisted stem cell extract | |
| CA2947392C (en) | Apparatus and method for multiwavelength photodynamic therapy | |
| CN101559257A (zh) | 一种红光活血仪 | |
| CN204307223U (zh) | 带氧管的激光光动力治疗仪 | |
| Paasch et al. | Update on dermatologic laser therapy II–advances in photodynamic therapy using laser‐assisted drug delivery | |
| CN202260121U (zh) | 一种多波长高功率半导体激光器光源系统 | |
| RU2010129236A (ru) | Способ лечения местнораспространенных онкологических заболеваний в эксперименте | |
| CN216255908U (zh) | 一种美容嫩肤美甲灯 | |
| CN112972906A (zh) | 基于红黄蓝三种波长增益的多功能led美容养身灯 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20180718 |